Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 23111-00-4
2. 3-carbamoyl-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride
3. 8xm2xt8vwi
4. Nicotinamide Ribose Chloride
5. Nicotinamide Riboside (chloride)
6. 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide;chloride
7. Ss-nicotinamide Riboside
8. Unii-8xm2xt8vwi
9. Srt647;niagen
10. Schembl17315043
11. Mfcd27952781
12. Hy-123033a
13. Ac-29830
14. Ws-00064
15. Cs-0098615
16. F20757
17. F20758
18. A901913
19. Eh-301 Component Nicotinamide Riboside Chloride
20. Pyridinium, 3-carbamoyl-1-beta-d-ribofuranosyl-, Chloride
21. Pyridinium, 3-(aminocarbonyl)-1-beta-d-ribofuranosyl-, Chloride
22. Pyridinium, 3-carbamoyl-1-.beta.-d-ribofuranosyl-, Chloride
23. Pyridinium, 3-(aminocarbonyl)-1-.beta.-d-ribofuranosyl-, Chloride
24. 3-carbamoyl-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-iumchloride
25. 3-carbamoyl-1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridinium Chloride
Molecular Weight | 290.70 g/mol |
---|---|
Molecular Formula | C11H15ClN2O5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 290.0669493 g/mol |
Monoisotopic Mass | 290.0669493 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 314 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Nicotinamide riboside (chloride) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nicotinamide riboside (chloride), including repackagers and relabelers. The FDA regulates Nicotinamide riboside (chloride) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nicotinamide riboside (chloride) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nicotinamide riboside (chloride) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nicotinamide riboside (chloride) supplier is an individual or a company that provides Nicotinamide riboside (chloride) active pharmaceutical ingredient (API) or Nicotinamide riboside (chloride) finished formulations upon request. The Nicotinamide riboside (chloride) suppliers may include Nicotinamide riboside (chloride) API manufacturers, exporters, distributors and traders.
click here to find a list of Nicotinamide riboside (chloride) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nicotinamide riboside (chloride) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nicotinamide riboside (chloride) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nicotinamide riboside (chloride) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nicotinamide riboside (chloride) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nicotinamide riboside (chloride) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nicotinamide riboside (chloride) suppliers with NDC on PharmaCompass.
Nicotinamide riboside (chloride) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nicotinamide riboside (chloride) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nicotinamide riboside (chloride) GMP manufacturer or Nicotinamide riboside (chloride) GMP API supplier for your needs.
A Nicotinamide riboside (chloride) CoA (Certificate of Analysis) is a formal document that attests to Nicotinamide riboside (chloride)'s compliance with Nicotinamide riboside (chloride) specifications and serves as a tool for batch-level quality control.
Nicotinamide riboside (chloride) CoA mostly includes findings from lab analyses of a specific batch. For each Nicotinamide riboside (chloride) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nicotinamide riboside (chloride) may be tested according to a variety of international standards, such as European Pharmacopoeia (Nicotinamide riboside (chloride) EP), Nicotinamide riboside (chloride) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nicotinamide riboside (chloride) USP).
LOOKING FOR A SUPPLIER?